Assessing Adaptive Biotechnologies (ADPT) Valuation After a 179% One-Year Rebound and Recent Pullback [Yahoo! Finance]
Adaptive Biotechnologies (NASDAQ:ADPT) was given a new $21.00 price target on by analysts at Morgan Stanley.
Adaptive Biotechnologies Announces Nearly 90 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 67th ASH Annual Meeting
Adaptive Biotechnologies (ADPT) Hits 3-Year High. Here's Why [Yahoo! Finance]
Continued Momentum Lifted Adaptive Biotechnologies Corporation (ADPT) in Q3 [Yahoo! Finance]